Product Information

EDARBYCLOR 40-25 MG TABLET is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $8.4880 per EA under NDC 60631042530. Its NADAC has been published 600 times since Feb 25, 2015.

FDA first approved this application on Dec 20, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EDARBYCLOR 40-25 MG TABLET

Azilsartan kamedoxomil and chlorthalidone
$8.4880per EA

Strength

40; 25 mg/1; mg/1

NDC

60631042530

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA202331

FDA Approved

12/20/2011

TE Code

AB

On Market Since

2/1/2013

Pharmacological Classes

Angiotensin 2 Receptor Blocker
Angiotensin 2 Type 1 Receptor Antagonists
Decreased Blood Pressure
Increased Diuresis
Thiazide-like Diuretic

Price Statistics

The NADAC for EDARBYCLOR 40-25 MG TABLET has been published 600 times since Feb 25, 2015, and over the history we have for it it has risen 88.2%. The table below summarizes its recorded NADAC range and movement.

Current price$8.4880 per EA
All-time high$8.5037 (May 14, 2025)
All-time low$4.5107 (Feb 25, 2015)
52-week high$8.4978
52-week low$8.4510
Median price$6.4445
Average price$6.5846
Largest weekly change+10.0% (Dec 27, 2023)
Weeks tracked600
Tracking sinceFeb 25, 2015

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

-0.0%

1Y

+0.4%

3Y

+19.2%

5Y

+28.0%

All

+88.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Azilsartan kamedoxomil and chlorthalidone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of EDARBYCLOR 40-25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EDARBYCLOR 40-25 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $8.4880 per EA (NDC 60631042530), effective Aug 19, 2026.

How has the price of EDARBYCLOR 40-25 MG TABLET changed over time?

Over the history we have for it, the NADAC for EDARBYCLOR 40-25 MG TABLET has risen 88.2%. It has been tracked across 600 weekly CMS publications since Feb 25, 2015.

What are the highest and lowest recorded NADAC prices for EDARBYCLOR 40-25 MG TABLET?

Since Feb 25, 2015, the NADAC for EDARBYCLOR 40-25 MG TABLET has ranged from a low of $4.5107 (Feb 25, 2015) to a high of $8.5037 (May 14, 2025), with a median of $6.4445 per EA.

Are there cheaper alternatives to EDARBYCLOR 40-25 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of EDARBYCLOR 40-25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures EDARBYCLOR 40-25 MG TABLET?

EDARBYCLOR 40-25 MG TABLET (NDC 60631042530) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.